PARI REUSABLE NEBULIZERS

LC ® Sprint
LC ® Plus
PA R I R E U S A B L E N E B U L I Z E R S
Clinically proven reusable nebulizers
FAST treatments – 5-6 minutes 1
Saves money by wasting less medication
Breath-Enhanced design delivers consistent particle size &
targeted delivery to the lungs
Easy to clean – hand wash, boilable and dishwasher safe
Easy to use for all ages
Covered by insurance every 6 months 2
PARI Respiratory Equipment, Inc.
|
2412 PARI Way, Midlothian, VA 23112 USA
|
Tel: 800.FAST.NEB (327.8632) and 804.253.7274
|
Fax: 800.727.4112
|
Product.Info@PARI.com
|
www.PARI.com
PARI REUSABLE NEBULIZERS
I N C L U D I N G PA R I T I M E S T R I P
C O N F I G U R AT I O N S
®
NDC No.
HCPCS No.
023F35
83490-0230-01
A7005
PARI LC Plus
022F81
83490-0220-28
A7005
PARI LC ®
Sprint Retail
023F35-R
83490-0230-11
A7005
PARI LC ®
Plus Retail
022F81-R
83490-0221-36
A7005
Part No.
PARI LC ® Sprint
®
Activated
6 Months Later
S P E C I F I C AT I O N S
Easy to use visual indicator
PARI LC ® Sprint Performance 1:
Reminds patients to replace their PARI
nebulizer every 6 months
Helps maintain FAST treatments & reduce
bacterial contamination 3
Total Output Rate
500 mg/min
MMD
3.5 µm
% RF
68%
Average Treatment Time
~5 min
PARI LC ® Plus Performance 1:
THE DIFFERENCE
IS IN THE DELIVERY
4
Total Output Rate
440 mg/min
MMD
3.8 µm
% RF
65%
Average Treatment Time
6-7 min
Accessories
Drug Delivered to the Lungs
Budesonide RDD [mg]
56
044F7248
PARI Adult Aerosol Mask
044F7251
40
PARI reusable nebulizers were used in the following
clinical trials to prove safety and efficacy †:
24
Pulmicort Respules ® - AstraZeneca
Perforomist™, Accuneb ®, and Duoneb ® - Dey
8
Drug Delivered to the Lungs Per Minute
14
Budesonide RDDR [mg/min]
Bubbles the Fish™ II
pediatric mask
Pulmozyme ® - Genentech, Inc.
TOBI ® - Novartis
Xopenex ® and Brovana ® - Sunovion
10
Tested with a 1.2 bar compressor. Measured with Malvern
MasterSizer X at 50% relative humidity, 0.9% NaCl solution,
inspiratory flow 20 liters/minute,
continuous nebulization, 23° C, fill volume 2.5 ml.
2
Insurance coverage varies by provider
3
Lester, et al. Nebulizer Use and Maintenance by Cystic Fibrosis
Patients: A Survey Study. Respiratory Care 2004; 49(12): 15041508.
4
Weigand, et al. Using RDDR to Compare Delivery Efficiency
of Three Commercially Available Breath-Enhanced Nebulizers with
Budesonide. CHEST October 2008
†
Trademarks are the property of their respective companies.
1
6
2
PARI Respiratory Equipment, Inc.
|
2412 PARI Way, Midlothian, VA 23112 USA
|
Tel: 800.FAST.NEB (327.8632) and 804.253.7274
|
Fax: 800.727.4112
© 2012 PARI Respiratory Equipment, Inc. All rights reserved. 023D0212 Rev B 6-12
|
Product.Info@PARI.com
|
www.PARI.com